Search Results
Mar 12, 2026, 16:30 ET NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES EARLY DECLARATION OF REGULAR MONTHLY DISTRIBUTION
NEW YORK, March 12, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced an early declaration of the Fund's regular monthly distribution payable in April. The $0.0905 per share of common stock
More news about: Neuberger Berman
Mar 11, 2026, 09:00 ET Kneu Health Graduates from Texas Medical Center Innovation Accelerator as U.S. Deployments Expand
intervention and personalized care. Backed by Oxford Science Enterprises, Cedars-Sinai, and a global syndicate of investors, Kneu operates across eight NHS Trusts and flagship U.S. health systems. Learn more at
More news about: Kneu Health
Mar 09, 2026, 09:00 ET Kneu Health Validates Precision Neurology Platform in Cedars-Sinai Clinical Deployment
Parkinson's tremor measurement and is expanding adoption across U.S. academic and specialty health systems, with additional deployment across multiple NHS Trusts in the United Kingdom. The Cedars-Sinai clinical integration builds on more than a decade of Oxford's neurological research, and reflects the
More news about: Kneu Health
Mar 05, 2026, 07:00 ET Hemab Therapeutics Receives FDA Breakthrough Therapy Designation for Sutacimig in Glanzmann Thrombasthenia
unmet need for people living with Glanzmann thrombasthenia is clear," said Suthesh Sivapalaratnam, MD, PhD, Consultant Haematologist at Barts Health NHS Trust and Associate Professor at Queen Mary University of London. "This Breakthrough Therapy Designation is a critical step towards a potentially better
More news about: Hemab Therapeutics
Mar 04, 2026, 14:15 ET GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES
Grail, Inc. (NASDAQ: GRAL) investors lost approximately half the value of their holdings when the stock plunged roughly 50% following disclosure that the NHS Galleri trial missed its primary endpoint. If you lost money on GRAL,
More news about: Levi & Korsinsky, LLP
Mar 04, 2026, 09:00 ET Lunit to Be Featured in 21 AI Imaging Studies on Breast Cancer and Lung Disease at ECR 2026
led by Professor Yan Chen at the University of Nottingham evaluated the applicability of AI in the interval cancer classification process of the UK's NHS Breast Screening Programme (NHSBSP). Currently, within the NHSBSP, two expert readers retrospectively review interval cancer cases and classify them
More news about: Lunit
Mar 04, 2026, 02:30 ET ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis
through NHS Lothian and NHS Grampian in Scotland.Endometriosis is a chronic condition affecting ~190 million women. It is defined by the presence of endometrial-like tissue outside the uterus ('lesions'), commonly within the pelvis. Endometriosis costs the UK ~£8.2 billion per year in NHS costs
More news about: Ananda Pharma Limited
Mar 03, 2026, 15:50 ET Claigan Webinar - Beyond the Greenwash: A Technical Masterclass on LCA, EPD & PCR for Electronics
year-over-year improvements. Nobody wants to be shut out of a purchasing tender while their competitors gain the edge. And by 2028, all products sold to the NHS in the UK require specific carbon foot printing via the LCA process.Moving past the high-level overviews that dominate the industry, this webinar
More news about: Claigan Environmental Inc.
Feb 27, 2026, 16:30 ET NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
NEW YORK, Feb. 27, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on March 31,
More news about: Neuberger Berman
Feb 27, 2026, 08:33 ET New National Hardware Show Concept to Commerce Draws Major Industry Names to the Show Floor and Educational Programming
Hosted VIP Buyer Program at NHS Concept to Commerce offers qualified sourcing, product, and private label professionals an elevated NHS experience. The program includes travel support, VIP access on-site, and a complimentary ticket to the NHS Networking Party. Participants also benefit
More news about: NHS Concept to Commerce
Feb 26, 2026, 03:04 ET UK NHS Trust moves their Sectra imaging solution to the cloud--ensuring secure delivery of high-quality care
services that many NHS trusts are now initiating. Cloud-based solutions also need to scale as demands increase and support new ways of working over time, while remaining reliable in daily operations and flexible enough to grow with future needs. James Paget University Hospitals NHS Foundation Trust has
More news about: Sectra
Feb 25, 2026, 13:11 ET Waterborne disease poses rising global threat in both developed and developing nations, Hydrachem warns
disinfection and sterilisation. Operating in over 60 countries, the company partners with NGOs, governments and leading healthcare institutions, including the NHS, to combat waterborne diseases, maintain hygienic environments and produce over 10 billion litres of safe drinking water each year.Hydrachem
More news about: Hydrachem
Feb 24, 2026, 12:15 ET Illumina launches TruPath Genome, setting a new standard in genomic insight
identify possible precision treatments," said Emma Baple, PhD, professor of Genomic Medicine at the University of Exeter and medical lead for the NHS England Rapid Genome Sequencing Service for Critically Unwell Children. "In Exeter, we have been privileged to evaluate the TruPath technology and
More news about: Illumina, Inc.
Feb 24, 2026, 10:04 ET Flexzo Ai and Island Doctors Announce Multi-Site Partnership to Deploy AI-Driven Workforce Automation Across Florida
our providers can focus on what matters most, caring for patients."Originally launched in the United Kingdom, where it has helped multiple NHS Trusts dramatically reduce agency reliance while improving workforce efficiency, Flexzo Ai is now expanding its footprint across the United States. The
More news about: Flexzo Ai
Feb 24, 2026, 10:00 ET LARGEST-EVER STUDY OF CARDIAC SCREENING IN YOUNG PEOPLE SHOWS THAT HEART CHECKS IDENTIFY RISK & 'HIDDEN' CONDITIONS - AND SAVE LIVES
Cardiac Risk in the Young (CRY), a team of 25 researchers – based at City St George's, University of London and St George's University Hospitals NHS Foundation Trust - analysed outcomes from more than 104,000 young people aged 14 to 35 (with a median age of 23) who'd had their hearts tested
More news about: Cardiac Risk in the Young
Feb 24, 2026, 08:10 ET GRAL INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into GRAIL, Inc., Encourages Investors and Potential Witnesses to Contact Law Firm
company, providing multi-cancer early detection testing and services.THE REVELATION: On February 19, 2026, GRAIL announced results for its NHS-Galleri trial, which evaluated annual multi-cancer screening with GRAIL's Galleri test, revealing that "[t]he primary endpoint of statistically significant
More news about: Robbins Geller Rudman & Dowd LLP
Feb 24, 2026, 04:00 ET Kyndryl and University of Liverpool to Spearhead Health Innovation with Agentic AI
conversational AI services, such as voice agents, to help patients record how they feel, how well they use medicines, and how to make the best use of the NHS and social care services.The projects launched under the collaboration between Kyndryl and the University will contribute to a shared library
More news about: Kyndryl
Feb 24, 2026, 03:30 ET 真肥或假瘦都會好傷身 全城投入反「胖」健康基地 一齊智退肥胖威脅
https://iris.who.int/server/api/core/bitstreams/53228dc6-9520-421b-b5a2-f826967090cb/content [5] NHS. Obesity. https://www.nhs.uk/conditions/obesity/
More news about: 諾和諾德
Feb 19, 2026, 16:02 ET GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results
include:Announced topline results from the landmark, randomized, controlled NHS-Galleri trial, which evaluated annual screening with the Galleri® test in England's National Health Service (NHS) over three years in 142,000 demographically representative participants aged 50 to 77. The results
More news about: GRAIL, Inc.
Feb 19, 2026, 16:01 ET Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate
cured, today announced topline results from the landmark, randomized, controlled NHS-Galleri trial, which evaluated annual multi-cancer screening with the Galleri® test in England's National Health Service (NHS) over three years in 142,000 demographically representative participants aged 50
More news about: GRAIL, Inc.
Feb 19, 2026, 08:00 ET NOVOS Core Clinical Trial Reveals Cardiovascular Benefits in Aging Adults
as possible."About the Study The study was conducted independently by investigators at the University of Surrey and affiliated NHS institutions. NOVOS provided the study product and an unrestricted research grant but had no role in data collection. The academic authors retained full
More news about: NOVOS Labs
Feb 19, 2026, 02:55 ET North West London NHS trusts unify imaging with Sectra's cloud platform to boost collaboration and speed diagnoses
agreement to migrate two of its existing NHS customers in North West London to a joint, fully managed cloud service for enterprise imaging, Sectra One Cloud. By consolidating London North West University Healthcare NHS Trust and Chelsea and Westminster Hospital NHS Foundation Trust onto a single cloud service,
More news about: Sectra
Feb 12, 2026, 04:15 ET Oracle Health Clinical AI Agent, Clinical Note Helps UK Doctors Spend More Time on Patient Care
at the NHS and private practices to use an ambient voice and screen-driven assistant to draft patient notes, so they can reduce administrative tasks and devote more time to patient care. Trusts participating in the pilot program, including Barts Health NHS Trust, Imperial College Healthcare NHS Trust,
More news about: Oracle
Feb 11, 2026, 16:09 ET DXC 於倫敦設立客戶體驗中心，助力企業發揮人工智能價值
商業世界瞬息萬變，指數級成長已成常態，領袖人物更加需要可靠夥伴，並肩設計、建構並營運人工智能推動的企業藍圖。 此處遠遠不止於展示技術及解決方案， 更是客戶轉型過程的延伸平台。」客戶體驗中心將服務區內多間重量級公營及私營機構，涵蓋倫敦警務處 (Metropolitan Police)、英國鐵路網公司 (Network Rail)、巴特醫療國民保健署信託 (Barts Health NHS Trust)、倫敦保險市場公司 (London Market Insurance Companies)、國防部 (Ministry of Defence) 及衛生與社會關懷部 (Department of Health & Social Care) 等，助其加快數碼轉型。DXC
More news about: DXC Technology Company
Feb 11, 2026, 15:04 ET DXC lança Centro de Experiência do Cliente em Londres para ajudar a explorar o valor da IA
algumas das organizações mais importantes dos setores público e privado da região, incluindo a Polícia Metropolitana, a Network Rail, a Barts Health NHS Trust, as seguradoras do mercado de Londres, o Ministério da Defesa e o Departamento de Saúde e Assistência Social, ajudando-as a acelerar a transformação
More news about: DXC Technology Company